Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/23/1997 | US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor |
12/23/1997 | US5700778 Inhibit synaptic transmission |
12/23/1997 | US5700777 Fatty acid - pulmonary surfactant conjugates |
12/23/1997 | US5700776 Medicaments comprising glicentin as active ingredient |
12/23/1997 | US5700770 Dye transfer inhibition and novel peroxidase |
12/23/1997 | US5700683 Virulence-attenuating genetic deletions deleted from mycobacterium BCG |
12/23/1997 | US5700682 Mechanism based screen for retinoid X receptor agonists and antagonists |
12/23/1997 | US5700680 Fusion proteins |
12/23/1997 | US5700678 Protein disulfide-isomerase and production thereof |
12/23/1997 | US5700677 Protein analogues of tissue plasminogen activator |
12/23/1997 | US5700665 Method for the extraction of periplasmic proteins from prokaryotic microorganisms in the presence of arginine |
12/23/1997 | US5700664 For pharmaceutical preparations for stimulating cells involved in immune response and proper functioning of hematopoietioc system |
12/23/1997 | US5700663 Modified at one or more potential glycosylation sites or at the arginine 393 position |
12/23/1997 | US5700662 Culturing a genetic engineered host cell, gene expressing a dna, encoding a proinsulin, enzymatically disconnecting |
12/23/1997 | US5700658 Purified, isolated polynucleotide coding for intercellular adhesion molecule protein |
12/23/1997 | US5700657 Vectors and vector systems including genes encoding tumor suppressor proteins and producer cells transformed thereby |
12/23/1997 | US5700650 Mechanism-based screen for retinoid X receptor agonists and antagonists |
12/23/1997 | US5700649 Method of detection of urinary tumor associated antigen |
12/23/1997 | US5700648 Streptolysin O antigen derivatives, their production and uses |
12/23/1997 | US5700643 Stable DNA constructs |
12/23/1997 | US5700638 Cell death regulator |
12/23/1997 | US5700635 HIV-1 gag cytotoxic T-lymphocyte epitope and method of use |
12/23/1997 | US5700469 HIV-1 core protein fragments |
12/23/1997 | US5700466 Culture product from hybridoma cell |
12/23/1997 | US5700461 Method for inhibiting HIV replication using IL-4 |
12/23/1997 | US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases |
12/23/1997 | US5700354 High strength, tensile strength |
12/23/1997 | US5700353 Paper strengthened with solubilized collagen and method |
12/23/1997 | CA2084663C Non-hygroscopic mono-ammonium salts |
12/23/1997 | CA1339596C Viral expression inhibitors |
12/21/1997 | CA2208724A1 Expression of the alpha-toxin gene (hla) of staphylococcus aureus using a chromosomally encoded hla-lacz gene fusion |
12/19/1997 | CA2208202A1 Novel proteinase inhibitor and gene encoding the inhibitor |
12/18/1997 | WO1997047971A1 Methods and compositions for the use of apurinic/apyrimidinic endonucleases |
12/18/1997 | WO1997047772A2 Ataxia-telangiectasia: mutations in the atm gene |
12/18/1997 | WO1997047771A1 Editing-based selectable plastid marker genes |
12/18/1997 | WO1997047758A1 Methods and compositions for transforming cells |
12/18/1997 | WO1997047755A1 Method for the expression of foreign genes and vectors therefor |
12/18/1997 | WO1997047754A1 Transcriptional silencing elements and their binding factors |
12/18/1997 | WO1997047748A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use |
12/18/1997 | WO1997047746A1 A method for increasing hemoprotein production in filamentous fungi |
12/18/1997 | WO1997047745A1 Plant retinoblastoma-associated proteins |
12/18/1997 | WO1997047744A2 T-cell selective interleukin-4 agonists |
12/18/1997 | WO1997047743A1 Human type ii gonadotropin-releasing hormone receptor |
12/18/1997 | WO1997047742A1 Hr-1 receptor |
12/18/1997 | WO1997047741A1 Hr-1 receptor |
12/18/1997 | WO1997047740A2 VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN |
12/18/1997 | WO1997047737A1 Recombinant blood-coagulation proteases |
12/18/1997 | WO1997047735A1 Method of activating denatured protein |
12/18/1997 | WO1997047732A2 Hexameric fusion proteins and uses therefor |
12/18/1997 | WO1997047731A2 Suppression of specific classes of soybean seed protein genes |
12/18/1997 | WO1997047652A1 Purification of soluble laminin 5 |
12/18/1997 | WO1997047651A1 Modified factor vii |
12/18/1997 | WO1997047650A1 Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
12/18/1997 | WO1997047649A1 Paralysis tick neurotoxin |
12/18/1997 | WO1997047648A1 T cell epitope peptide |
12/18/1997 | WO1997047647A1 Plant proteins |
12/18/1997 | WO1997047646A1 Helicobacter pylori adhesin binding group antigen |
12/18/1997 | WO1997047644A1 T cell antigen receptor peptides |
12/18/1997 | WO1997047641A1 Nucleotide sugar transporters and uses thereof |
12/18/1997 | WO1997047358A1 Synthetic hepatitis c genes |
12/18/1997 | WO1997047321A1 Use of chimeric vaccinia virus complement control proteins to inhibit complement |
12/18/1997 | WO1997047319A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047318A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | WO1997047316A1 Screening methods for compounds useful in the regulation of body weight |
12/18/1997 | WO1997047314A1 Use of substrate subtraction libraries to distinguish enzyme specificities |
12/18/1997 | WO1997047312A1 Novel heparin binding peptides |
12/18/1997 | WO1997047306A1 δ-ERYTHROID KRÜPPEL-LIKE FACTORS AND METHODS OF USE |
12/18/1997 | WO1997047197A1 Compositions and methods for administering borrelia dna |
12/18/1997 | WO1997047183A1 Genes enhancing disease resistance in plants |
12/18/1997 | WO1997047172A1 Vitamin d receptor isoform protein |
12/18/1997 | WO1997043419A3 The spindly gene, methods of identification and use |
12/18/1997 | WO1997041823A3 MOLECULAR GENETIC CONSTRUCTION OF VACCINE STRAINS OF $i(PASTEURELLACEAE) |
12/18/1997 | WO1997040148A3 Peptide antagonists derived from the transmembrane domains of g protein-coupled receptors |
12/18/1997 | WO1997035982A3 Monocyte chemotactic protein-5 materials and methods |
12/18/1997 | WO1997035194A3 Enantiomeric screening process, and compositions therefor |
12/18/1997 | WO1997035023A3 Alteration of amino acid compositions in seeds |
12/18/1997 | WO1997029183A3 Methods and compositions for transforming dendritic cells and activating t cells |
12/18/1997 | WO1997024451A3 Episomal vector and uses thereof |
12/18/1997 | DE19724546A1 Composition for treating cancer, containing proteins and/or peptide(s) |
12/18/1997 | CA2258127A1 Genes enhancing disease resistance in plants |
12/18/1997 | CA2258016A1 Compositions and methods for administering borrelia dna |
12/18/1997 | CA2258007A1 Methods and compositions for transforming cells |
12/18/1997 | CA2257991A1 Uses of a chemokine receptor for inhibiting hiv-1 infection |
12/18/1997 | CA2257972A1 Plant proteins |
12/18/1997 | CA2257873A1 Use of substrate subtraction libraries to distinguish enzyme specificities |
12/18/1997 | CA2257861A1 Hexameric fusion proteins and uses therefor |
12/18/1997 | CA2257857A1 Screening methods for compounds useful in the regulation of body weight |
12/18/1997 | CA2257828A1 Plant retinoblastoma-associated proteins |
12/18/1997 | CA2257614A1 Novel heparin binding peptides |
12/18/1997 | CA2257137A1 Synthetic hepatitis c genes |
12/18/1997 | CA2257111A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use |
12/18/1997 | CA2256761A1 Modified factor vii |
12/18/1997 | CA2256710A1 Vaccine containing a peroxiredoxin and/or a .beta.-tubulin |
12/18/1997 | CA2256459A1 T-cell selective interleukin-4 agonists |
12/18/1997 | CA2226945A1 Method for expressing foreign genes and vectors therefor |
12/17/1997 | EP0812917A1 Cold-inducible promoter sequences |
12/17/1997 | EP0812913A2 HR-1 receptor, a receptor of the cytokine receptors family |
12/17/1997 | EP0812858A1 Process for the preparation of a composition containing factor VIII |
12/17/1997 | EP0812421A1 Anti dna antibody detection involving telomeric dna sequence recognition and binding |
12/17/1997 | EP0812362A1 A plasmid for expressing modified recombinant proteins in a bacterial system |